Movatterモバイル変換

[0]ホーム
URL:

GB2454615A - Antidiabetic azabicyclo (3.1.0) hexan compounds - Google Patents

Antidiabetic azabicyclo (3.1.0) hexan compoundsDownload PDF

Info

Publication number
GB2454615A
GB2454615AGB0902845AGB0902845AGB2454615AGB 2454615 AGB2454615 AGB 2454615AGB 0902845 AGB0902845 AGB 0902845AGB 0902845 AGB0902845 AGB 0902845AGB 2454615 AGB2454615 AGB 2454615A
Authority
GB
United Kingdom
Prior art keywords
compounds
hexan
antidiabetic
azabicyclo
stereoisomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0902845A
Other versions
GB0902845D0 (en
Inventor
Sudershan Kumar Arora
Neelima Sinha
Prathap Nair
Ajay Tilekar
Nabendu Saha
Talha Khan
Reeba Vikramadithyan
Rajesh Gupta
Sai Kumar Chakka
Navnath Popat Karche
Prasad Purushottam Dixit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin LtdfiledCriticalLupin Ltd
Publication of GB0902845D0publicationCriticalpatent/GB0902845D0/en
Publication of GB2454615ApublicationCriticalpatent/GB2454615A/en
Withdrawnlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention provides novel compounds of the general formula (I), wherein the symbols are same as described in specification, their pharmaceutically acceptable salts, their tautomeric forms, their stereoisomers, pharmaceutical compositions containing them, to process and intermediates for the preparation of the above said compounds, having the utility of these compounds in medicine and to methods for their therapeutic use, and their use in the treatment of diabetes and related diseases.
GB0902845A2006-07-212007-07-20Antidiabetic azabicyclo (3.1.0) hexan compoundsWithdrawnGB2454615A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
IN730KO20062006-07-21
PCT/IN2007/000298WO2008010238A2 (en)2006-07-212007-07-20Antidiabetic azabicyclo [3. 1. 0] hexan compounds

Publications (2)

Publication NumberPublication Date
GB0902845D0 GB0902845D0 (en)2009-04-08
GB2454615Atrue GB2454615A (en)2009-05-13

Family

ID=38812084

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0902845AWithdrawnGB2454615A (en)2006-07-212007-07-20Antidiabetic azabicyclo (3.1.0) hexan compounds

Country Status (3)

CountryLink
AU (1)AU2007274598A1 (en)
GB (1)GB2454615A (en)
WO (1)WO2008010238A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2025674A1 (en)2007-08-152009-02-18sanofi-aventisSubstituted tetra hydro naphthalines, method for their manufacture and their use as drugs
FR2932479A1 (en)*2008-06-132009-12-18Servier Lab NOVEL AZABICYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO2011107494A1 (en)2010-03-032011-09-09SanofiNovel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
DE102010015123A1 (en)2010-04-162011-10-20Sanofi-Aventis Deutschland GmbhNew benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels
WO2011157827A1 (en)2010-06-182011-12-22SanofiAzolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)2010-06-212013-09-10SanofiHeterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)2010-07-052012-04-16Sanofi Sa(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)2010-07-052012-06-01Sanofi SaAryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)2010-07-052012-04-16Sanofi AventisSpirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en)2011-09-122013-03-21Sanofi6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2758041B1 (en)2011-09-202021-01-13Basf SeLow-molecular modulators of the cold-menthol receptor trpm8 and use of same
WO2013045413A1 (en)2011-09-272013-04-04Sanofi6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en)2011-11-082013-05-16INSERM (Institut National de la Santé et de la Recherche Médicale)Methods for the diagnosis and treatment of male infertility
SG11202113129UA (en)2019-05-312021-12-30Ikena Oncology IncTead inhibitors and uses thereof
MX2021014441A (en)2019-05-312022-01-06Ikena Oncology IncTead inhibitors and uses thereof.
CN110237045A (en)*2019-07-112019-09-17广西大学 a capsule

Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1999062872A1 (en)*1998-06-041999-12-09Astrazeneca AbNew 3-aryl-2-hydroxypropionic acid derivative (i)
WO2004089898A1 (en)*2003-04-092004-10-21Ranbaxy Laboratories LimitedSubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1999062872A1 (en)*1998-06-041999-12-09Astrazeneca AbNew 3-aryl-2-hydroxypropionic acid derivative (i)
WO2004089898A1 (en)*2003-04-092004-10-21Ranbaxy Laboratories LimitedSubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, Vol. 16, No. 15, 2006, (Kuhn; Hilpert B et al), pages 4016 - 4020, ISSN 0960-894X*
JOURNAL OF MEDICINAL CHEMISTRY, Vol. 45, No. 4, 2002, (SAUERBERG PER; ET AL), pages 789 - 804, ISSN 0022-2623*

Also Published As

Publication numberPublication date
WO2008010238A3 (en)2008-04-17
GB0902845D0 (en)2009-04-08
WO2008010238A2 (en)2008-01-24
AU2007274598A1 (en)2008-01-24

Similar Documents

PublicationPublication DateTitle
GB2454615A (en)Antidiabetic azabicyclo (3.1.0) hexan compounds
EA201270492A1 (en) COMPOUNDS FOR THE TREATMENT OF DISLIPIDEMIC AND RELATED DISEASES
MX2010009922A (en)Pyridazinone glucokinase activators.
MX2011012337A (en)Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases.
MY146662A (en)Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
MX2009010059A (en)Quinoline derivatives for the treatment of inflammatory diseases.
MX2012001985A (en)3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives.
MY179527A (en)Catecholamine derivatives useful for the treatment of parkinson's disease
EA201001585A1 (en) DERIVATIVES OF THYENOPYRIDONE AS AMP-ACTIVATED PROTEINKINASE (AMRC) ACTIVATORS
TNSN08283A1 (en)Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
SG155961A1 (en)Pyrazoles as 11-beta-hsd-1
MX2009006742A (en)Novel compounds.
TW200833663A (en)Therapeutic agents
TW200716547A (en)Piperidin-4-yl-amide derivatives
UA93393C2 (en)1,3-dioxane carboxylic acids
DE602008001725D1 (en) 1- (1-BENZYLPIPERIDIN-4-YL) BENZIMIDAZOLE-5-CARBOXYLENE DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS
GEP20166483B (en)Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament
MX2010009022A (en)16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use.
PH12013501393A1 (en)Heterocyclic compounds suitable for the treatment of dyslipidemia
WO2009125434A3 (en)Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
MY183111A (en)3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MX2009006010A (en)Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases.
MY146802A (en)Novel drugs for treating respiratory diseases
MX2009002906A (en)Pyridine derivatives for the treatment of metabolic disorders related insulin resistance or haperglycemia.
TW200738611A (en)9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Legal Events

DateCodeTitleDescription
WAPApplication withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp